Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation... see more

OTCPK:GBGPF - Post Discussion

GB Group Ord Shs > Synopsis on CMED
View:
Post by Valkrie99 on Nov 10, 2017 1:40pm

Synopsis on CMED

Just starting looking at this company.
It's market cap is shockingly low.
Can anyone give me a quick overview as to why it hasn't moved?
It seems to have a great potential.
Comment by 3yearpotstocks on Nov 10, 2017 2:51pm
From what I've seen since the ipo: PROs: -Focus on oils -Recent completion of capsule production facility -Excellent international exposure which has higher margins -No US exposure (Michigan site project is on-hold) -'Experienced management team' -Shares are tightly held Cons: -Poor social media presence and lacking active media publications which drive share prices in the sector ...more  
Comment by VENMan on Nov 10, 2017 8:58pm
These guys at CMED know what they're doing. It's the only cannabis stock I want to own. Rather than compare market caps let compare dilution through financings. Without getting into to much detail lets just look at the last 1.5 years and see the gross dilution other cannabis stocks have done in comparison to CMED. Lets start with WEED $245M, $25M, $40M, $24.5M, $60M, $34.5M = 6 deals huge ...more  
GB Group Ord Shs
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities